📊 Score Breakdown
Offering Ability
40
Cash Runway
10
Float Risk
40
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
38%
🔄 Reverse Split
55%
• 50-day avg $0.02 below $1 exchange minimum
📉 Score Deterioration
25%
• Score increased 10 points recently (worsening)
💰 Capital Raise
18%
• Active ATM program with $3M remaining capacity
💹 Market Data
Market Cap$16.74M
Shares Outstanding789.55M
FloatN/A
Cash$1.31M
Debt$2.76M
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest68.7K
Days to Cover1.0
% of FloatN/A
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2026
xbrl
XBRL CONVERTIBLE
Dec 31, 2021
424B3
ATM
Apr 30, 2026
EFFECT
EFFECT
Apr 28, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for NEWH
📊 NEWH FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 NEWH Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.